BSE Live
Jan 14, 16:01Prev. Close
260.95
Open Price
262.30
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Key Financial Ratios of Trident Texofab (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | |
| Per Share Ratios | ||||
| Basic EPS (Rs.) | 0.73 | 0.90 | 0.49 | |
| Diluted EPS (Rs.) | 0.73 | 0.90 | 0.49 | |
| Cash EPS (Rs.) | 11.20 | 13.33 | 8.02 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 103.50 | 97.32 | 87.21 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 103.50 | 97.32 | 87.21 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 1,885.43 | 2,444.93 | 1,394.72 | |
| PBDIT/Share (Rs.) | 38.40 | 52.00 | 41.21 | |
| PBIT/Share (Rs.) | 32.63 | 47.67 | 38.10 | |
| PBT/Share (Rs.) | 7.51 | 11.59 | 10.04 | |
| Net Profit/Share (Rs.) | 5.43 | 9.00 | 4.92 | |
| Profitability Ratios | ||||
| PBDIT Margin (%) | 2.03 | 2.12 | 2.95 | |
| PBIT Margin (%) | 1.73 | 1.94 | 2.73 | |
| PBT Margin (%) | 0.39 | 0.47 | 0.72 | |
| Net Profit Margin (%) | 0.28 | 0.36 | 0.35 | |
| Return on Networth / Equity (%) | 5.24 | 9.24 | 5.63 | |
| Return on Capital Employed (%) | 3.89 | 4.19 | 2.87 | |
| Return on Assets (%) | 0.63 | 0.83 | 0.63 | |
| Total Debt/Equity (X) | 1.04 | 3.02 | 2.21 | |
| Asset Turnover Ratio (%) | 220.13 | 225.60 | 180.05 | |
| Liquidity Ratios | ||||
| Current Ratio (X) | 1.12 | 1.11 | 1.11 | |
| Quick Ratio (X) | 0.84 | 0.88 | 0.84 | |
| Inventory Turnover Ratio (X) | 9.46 | 12.20 | 8.45 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||
| Enterprise Value (Cr.) | 0.00 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 0.00 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 0.00 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | 0.00 | 0.00 | 0.00 |
26.08.2025
Trident Texofab Standalone June 2025 Net Sales at Rs 28.08 crore, up 9.2% Y-o-Y
19.06.2025
Trident Texofab Standalone March 2025 Net Sales at Rs 38.21 crore, up 26.63% Y-o-Y
04.02.2025
Trident Texofab Standalone December 2024 Net Sales at Rs 31.69 crore, up 37.72% Y-o-Y
21.10.2024
Trident Texofab Standalone September 2024 Net Sales at Rs 26.45 crore, up 13.99% Y-o-Y
26.08.2025
Trident Texofab Standalone June 2025 Net Sales at Rs 28.08 crore, up 9.2% Y-o-Y
19.06.2025
Trident Texofab Standalone March 2025 Net Sales at Rs 38.21 crore, up 26.63% Y-o-Y
04.02.2025
Trident Texofab Standalone December 2024 Net Sales at Rs 31.69 crore, up 37.72% Y-o-Y
21.10.2024
Trident Texofab Standalone September 2024 Net Sales at Rs 26.45 crore, up 13.99% Y-o-Y
05.04.2017
30.03.2017
29.03.2017
28.03.2017